4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-26-055799
Chief Financial Officer sold 13,653 shares at $20.02 ($273,333)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Bodenstedt Matthias · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-11 | Sale : show line 1 in the form 10b5-1 | −13,653 | $20.02 | $273,333 | 1,172,431 | D |
| Open-market sales · 13,653 sh · avg $20.02 · $273,333 | ||||||
Loading xslF345X06/ownership.xml…